Biologics represented 5% of the drugs prescribed in the U.S. in 2024, but they accounted for more than half of the country’s ...

FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Jefferies London Healthcare Conference 2025 November 18, 2025 12:00 PM ESTCompany ParticipantsMatthew Gline - CEO ...

Pharmaceutical stocks are getting more attention these days as the global drug market is expected to reach $1.21 trillion in 2025, showing why the industry matters so much. The growth is driven by new ...

Ontunisertib could become the first FDA-approved anti-fibrotic suitable for Crohn’s disease patients with symptomatic ...

Start your day with a light meal, unless your doctor has said otherwise. Be sure to dress comfortably and wear something that ...

You’ll encounter several unforgiving challenges in Where Winds Meet, from grueling dungeons to punishing boss battles, so healing is a must. Thankfully, ...

Patent reforms could address a problem that’s been driving rising prescription drug costs and create a more competitive ...

Dear Toni: I signed up for a supplemental Medicare Plan G and a Medicare Part D prescription drug plan, both of which started in January 2021. These two plans have served me well. I just received ...

(CNN) — When it comes to philanthropy, Billie Eilish has her money where her mouth is at the moment. The Grammy winner recently accepted the Music Innovator Award at the Wall Street Journal Magazine ...

Dear Heloise: After reading the suggestion about gifting a child’s tea set to a grandmother with a new granddaughter, I just had to say that any grandchild would love tea parties! I started tea ...